Sopharma AD-Sofia (XBUL:SFA) FFO


XBUL:SFA Sopharma AD-Sofia XBUL:SFA
59 GF Score
Price €1.92
GF Value €3.15
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia FFO?

FFO (Funds from operations) only applies to REITs.

XBUL:SFA
59GF Score
Sopharma AD-Sofia XBUL:SFA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sopharma AD-Sofia (XBUL:SFA) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of €1.92 is trading 39% below its estimated GF Value™ of €3.15. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for XBUL:SFA:

  • FFO:
  • GF Value™: €3.15 vs. price of €1.92 (39% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the XBUL:SFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sopharma AD-Sofia Business Description

Other Exchanges SPH:Poland3JR:Germany
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
59GF Score

Get the complete analysis for XBUL:SFA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.92
Price
€3.15
GF Value